Additional Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Palm Springs, CA
    Palm Springs CA. 92203
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Greensboro, NC
    Greensboro NC. 27403
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Shreveport, LA
    Shreveport LA. 71103
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Ajax, ON
    Ajax ON. L1S 2J5
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Phoenix, AZ
    Phoenix AZ. 85032
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Champaign, IL
    Champaign IL. 61822
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Newport Beach, CA
    Newport Beach CA. 92663
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Medical University of South Carolina
    Charleston SC. 29425
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    Paradigm Clinical Research Centers, LLC
    San Diego CA. 92108
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    UAB Lung Health Center
    Birmingham AL. 35233
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    The Lung Research Center, LLC
    Chesterfield MO. 63017
    View Details

  • A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

    El Paso Pulmonary Association
    El Paso TX. 79902
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    El Paso Pulmonary Association, P.A.
    El Paso TX. 79902
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Intermountain Medical Center
    Murray UT. 84107
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Temple University Hospital
    Philadelphia PA. 19140
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Summit Health
    Bend OR. 97701
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Hannibal Regional Healthcare System, Inc.
    Hannibal MO. 63401
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Vanderbilt University Medical Center
    Nashville TN. 37204
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Lowcountry Lung and Critical Care, PA
    Charleston SC. 29406
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Icahn School of Medicine at Mount Sinai
    New York NY. 10029
    View Details